2025. Processed Lentil Seed Powder as a Potential Matrix Base for Nutraceutical Tablets. Journal of Carcinogenesis. 23, 1 (Sep. 2025), 152–162. DOI:https://doi.org/10.64149/J.Carcinog.24.3.541-551.